Kymera Therapeutics shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Royal Bank of Canada
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $13M | 237k | 55.56 |
| 2025-06-30 | $7.0M | 156k | 44.84 |
| 2025-03-31 | $59k | 2.1k | 27.52 |
| 2024-12-31 | $171k | 4.4k | 39.06 |
| 2024-09-30 | $271k | 5.8k | 46.88 |
| 2024-06-30 | $125k | 4.2k | 29.88 |
| 2024-03-31 | $45k | 1.1k | 39.60 |
| 2023-12-31 | $303k | 12k | 25.58 |
| 2023-09-30 | $66k | 4.8k | 13.87 |
| 2023-06-30 | $67k | 2.8k | 24.10 |
| 2022-12-31 | $137k | 5.4k | 25.26 |
| 2022-09-30 | $10k | 460 | 21.74 |
| 2021-06-30 | $247k | 5.1k | 48.48 |
| 2021-03-31 | $89k | 2.3k | 39.16 |
| 2020-12-31 | $10k | 160 | 62.50 |